These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29673583)

  • 1. Novel artificial stool material for external quality assurance (EQA) on a fecal immunochemical test for hemoglobin (FIT): The confirmed utility of stable hemoglobin and an internal standard material.
    Yasui R; Yamada M; Takehara S; Sakurabayashi I; Watanabe K
    Clin Chim Acta; 2018 Aug; 483():76-81. PubMed ID: 29673583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Temperature and Time on Fecal Hemoglobin Stability in 5 Fecal Immunochemical Test Methods and One Guaiac Method.
    Catomeris P; Baxter NN; Boss SC; Paszat LF; Rabeneck L; Randell E; Serenity ML; Sutradhar R; Tinmouth J
    Arch Pathol Lab Med; 2018 Jan; 142(1):75-82. PubMed ID: 28967803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable hemoglobin concentration with fecal immunochemical test at high temperatures in a Caribbean colorectal cancer screening program.
    Blake SN; Kortlever TL; Verbrugge SE; van Vuuren AJ; Dekker E; van der Vlugt M; Hugtenburg JG
    Clin Chim Acta; 2024 Jun; 560():119723. PubMed ID: 38735515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin.
    Fraser CG; Allison JE; Halloran SP; Young GP;
    J Natl Cancer Inst; 2012 Jun; 104(11):810-4. PubMed ID: 22472305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Imperfect Compliance With Instructions for Fecal Sample Collection on Diagnostic Performance of 9 Fecal Immunochemical Tests.
    Gies A; Gruner LF; Schrotz-King P; Brenner H
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1829-1839.e4. PubMed ID: 30851476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of ten external quality assurance scheme (EQAS) materials for the faecal immunochemical test (FIT) for haemoglobin.
    O'Driscoll S; Piggott C; Bruce H; Benton SC
    Clin Chem Lab Med; 2020 Aug; 59(2):307-313. PubMed ID: 32772000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term frozen storage and thawing of stool samples on faecal haemoglobin concentration and diagnostic performance of faecal immunochemical tests.
    Gies A; Niedermaier T; Weigl K; Schrotz-King P; Hoffmeister M; Brenner H
    Clin Chem Lab Med; 2020 Feb; 58(3):390-398. PubMed ID: 31655793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
    Gastroenterology; 2017 Apr; 152(5):1217-1237.e3. PubMed ID: 27769517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
    Caviglia GP; Cabianca L; Fagoonee S; Gili FM
    Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial.
    van Roon AH; Hol L; van Vuuren AJ; Francke J; Ouwendijk M; Heijens A; Nagtzaam N; Reijerink JC; van der Togt AC; van Ballegooijen M; Kuipers EJ; van Leerdam ME
    Am J Gastroenterol; 2012 Jan; 107(1):99-107. PubMed ID: 22108450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of an artificial stool usable for the surveillance of faecal haemoglobin testing.
    Miike A; Ogawa Z; Sakurabayashi I
    Ann Clin Biochem; 2018 May; 55(3):394-399. PubMed ID: 28856900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
    Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
    Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?
    Lee E; Lee Y
    Ann Lab Med; 2018 Jan; 38(1):51-53. PubMed ID: 29071819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
    Am J Gastroenterol; 2017 Jan; 112(1):37-53. PubMed ID: 27753435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program.
    Chiang TH; Chuang SL; Chen SL; Chiu HM; Yen AM; Chiu SY; Fann JC; Chou CK; Lee YC; Wu MS; Chen HH
    Gastroenterology; 2014 Dec; 147(6):1317-26. PubMed ID: 25200099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
    Baxter NT; Koumpouras CC; Rogers MA; Ruffin MT; Schloss PD
    Microbiome; 2016 Nov; 4(1):59. PubMed ID: 27842559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.